MANTLE CELL LYMPHOMA - NATURAL-HISTORY DEFINED IN A SERIALLY BIOPSIED POPULATION OVER A 20-YEAR PERIOD

被引:144
作者
NORTON, AJ
MATTHEWS, J
PAPPA, V
SHAMASH, J
LOVE, S
ROHATINER, AZS
LISTER, TA
机构
[1] ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND
[2] ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DEPT MED STAT,LONDON EC1A 7BE,ENGLAND
关键词
NON-HODGKINS LYMPHOMA; MANTLE CELL LYMPHOMA; LOW GRADE B-CELL LYMPHOMA; HISTOLOGICAL TRANSFORMATION; CENTROCYTIC LYMPHOMA; DIFFUSE SMALL CLEAVED CELL LYMPHOMA; MANTLE ZONE LYMPHOMA;
D O I
10.1093/oxfordjournals.annonc.a059154
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The histological, immunological and molecular characteristics of mantle cell lymphoma have only recently been delineated. Amongst these characteristics possible factors of prognostic significance include histological growth pattern and blastoid change. Patients and methods: 66 previously untreated cases of mantle cell lymphoma were identified in a retrospective analysis. In 50 cases serial biopsies had been taken during the disease and in 20 cases autopsies had been performed. Besides established factors of prognostic significance, histological growth pattern and blastoid change were examined. Results: 32 patients achieved an initial complete remission or good partial remission with most cases relapsing or progressing within 2 years. The median survival was 36 months. Factors predicting a poor outcome were high presenting stage, age >70, low sodium, low albumin and splenomegaly. Blastoid transformation was also a poor prognostic feature, occurring in 32% of cases during life and in 70% of autopsies. Histological growth pattern had no influence on outcome. Conclusion: This study emphasises the difficulties in treating mantle cell lymphoma and the high frequency and prognostic importance of histological transformation.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 39 条
[1]   MANTLE CELL LYMPHOMA - A PROPOSAL FOR UNIFICATION OF MORPHOLOGICAL, IMMUNOLOGICAL, AND MOLECULAR-DATA [J].
BANKS, PM ;
CHAN, J ;
CLEARY, ML ;
DELSOL, G ;
DEWOLFPEETERS, C ;
GATTER, K ;
GROGAN, TM ;
HARRIS, NL ;
ISAACSON, PG ;
JAFFE, ES ;
MASON, D ;
PILERI, S ;
RALFKIAER, E ;
STEIN, H ;
WARNKE, RA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (07) :637-640
[2]  
BERGER F, 1994, BLOOD, V10, P2829
[3]   LYMPHOCYTIC LYMPHOMA OF INTERMEDIATE DIFFERENTIATION - MORPHOLOGIC, IMMUNOPHENOTYPIC, AND PROGNOSTIC FACTORS [J].
BOOKMAN, MA ;
LARDELLI, P ;
JAFFE, ES ;
DUFFEY, PL ;
LONGO, DL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (09) :742-748
[4]  
Brittinger G, 1984, Hematol Oncol, V2, P269
[5]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[6]  
CHENG AL, 1994, CANCER, V73, P706, DOI 10.1002/1097-0142(19940201)73:3<706::AID-CNCR2820730334>3.0.CO
[7]  
2-U
[8]  
COX DR, 1972, J R STAT SOC B, V34, P187
[9]   PRIMARY LYMPHOMA OF THE SMALL-INTESTINE - A CLINICOPATHOLOGICAL STUDY OF 119 CASES [J].
DOMIZIO, P ;
OWEN, RA ;
SHEPHERD, NA ;
TALBOT, IC ;
NORTON, AJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (05) :429-442
[10]  
DUGGAN MJ, 1990, CANCER, V66, P522, DOI 10.1002/1097-0142(19900801)66:3<522::AID-CNCR2820660320>3.0.CO